Cornerstone (CRTX) Sells Product Rights of Factive Tablets, Spectracef Family to Merus Labs (MSLI), Vansen
Go back to Cornerstone (CRTX) Sells Product Rights of Factive Tablets, Spectracef Family to Merus Labs (MSLI), Vansen| Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) | Delayed: 1.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.95 | 52 Week High | $10.37 | |||
| Open | $1.24 | 52 Week Low | $5.32 | |||
| Day High | $1.95 | P/E | 6.50 | |||
| Day Low | $1.95 | EPS | $0.30 | |||
| Volume | 55,048 | |||||
| MERUS LABS INTL (NASDAQ: MSLI) | Delayed: 1.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $1.90 | |||
| Open | $3160.92 | 52 Week Low | $0.85 | |||
| Day High | $1.30 | P/E | N/A | |||
| Day Low | $1.30 | EPS | $0.00 | |||
| Volume | 260,230 | |||||
